The epidemiology of salivary gland tumors worldwide is not very well defined. Although many studies on this subject have been undertaken, the data are generally focused on specific topics such as parotid gland neoplasms or tumors of the major salivary glands. We conducted a study to establish the prevalence and distribution of benign and malignant neoplasms of both the major and minor salivary glands at a single institution. We reviewed 244,204 cases that had come through our pathology department from January 1994 through December 2005 and found 235 cases of a salivary gland neoplasm (0.09%). The female-to-male ratio was 1.04:1, and the mean age of the patients was 47 years. Of the 235 neoplasms, 159 (67.66%) were located in the parotid gland, 34 (14.47%) in the submandibular gland, and 42 (17.87%) in the minor salivary glands. A total of 146 tumors (62.13%) were benign and 89 (37.87%) were malignant. Pleomorphic adenoma was the most common neoplasm, occurring in 98 cases (41.70%). The most common malignancy was mucoepidermoid carcinoma, with 27 cases (11.49%). Our data demonstrate that the characteristics of salivary gland tumors in a Turkish population at a single institution are similar to those reported in the literature worldwide. www.entjournal.com Get online Our site offers: Online Exclusives (fulllength articles you'll find only online), full-text content of the current print issue, ENT Clinics, News & Events, reader polls, subscription information, and Instructions for Authors.
Introduction
The worldwide prevalence of salivary gland tumors is not well established. 1, 2 Uncertainty in the prevalence of these tumors can be attributed to their uncommon nature, their morphologic heterogeneity, and the challenges encountered in classifying them consistently. 3, 4 The reported annual prevalence of all salivary gland tumors globally ranges from 0.4 to 13.5 cases per 100,000 population. 5, 6 Salivary gland tumors account for only 3 to 6% of all neoplasms of the head and neck region. 5, 7, 8 The reported prevalence of malignant salivary neoplasms ranges from 0.4 to 2.6 cases per 100,000 population. 1, 5, [9] [10] [11] [12] A large volume of literature has been written about the types of salivary gland tumors and their site distribution in different countries. 1, 3, 11, [13] [14] [15] [16] [17] [18] [19] [20] The most commonly involved site is the parotid gland, while the sublingual gland is affected only rarely. 21, 22 The most commonly reported benign and malignant neoplasms are pleomorphic adenoma and mucoepidermoid carcinoma, respectively. 5 We conducted a study to determine selected characteristics of patients with salivary gland tumors at a training and research hospital in Izmir, Turkey, which is the largest city in the Aegean Coast region of the country.
Patients and methods
We retrospectively reviewed 244,204 cases that had come through the pathology department at Ataturk Training and Research Hospital from January 1994 through December 2005. From this large sample, we identified 235 cases of salivary gland neoplasms. We compiled data on each patient's sex and age and the location of each tumor. We then reexamined all the pathology slides with hematoxylin and eosin and classified each according to the World Health Organization's 2005 criteria. 5 
Results
Incidence. Of the 244,204 cases, 235 (0.09%) involved a salivary gland neoplasm (table) .
Demographic data. These cases were almost evenly divided by sex; there were 120 females (51.06%) and 115 ENT-Ear, Nose & Throat Journal  March 2012 
and Warthin tumor (n = 31; 21.23%), and the two most common malignancies were mucoepidermoid carcinoma (n = 27; 30.34% of malignancies) and adenoid cystic carcinoma (n = 17; 19.10%) (table) . Type and site. Pleomorphic adenoma was the most common benign tumor at every salivary gland site. Mucoepidermoid carcinoma was the most common parotid malignancy, and adenoid cystic carcinoma was the most common submandibular and palatal malignancy (table).
Discussion
The categorization of salivary gland tumors as suggested by the World Health Organization 5 has been useful in daily practice worldwide. 23 This classification system encourages understanding of the biologic behavior of these neoplasms in relation to their histomorphologic patterns. This classification formed the basis of our study.
We believe that our findings at our hospital probably provide an accurate representation of the prevalence of salivary gland tumors in the Turkish population as ENT-Ear, Nose & Throat Journal  March 2012 salivary gland tumors. 4, 21, 22, 28, 33 With 31 cases, Warthin tumor was the second most common benign tumor (21.23%) in our series and the second most common tumor overall (13.19%) .
Although mucoepidermoid carcinoma is widely reported to be the most common primary salivary gland malignancy, 5, 34, 35 adenoid cystic carcinoma was found to be more common than mucoepidermoid carcinoma in some series. 11, 18, 28 In our study, mucoepidermoid carcinoma was the third most common salivary gland tumor overall (11.49%) and the most common of the 89 malignant tumors (30.34%), while the respective percentages for adenoid cystic carcinoma (n = 17) were 7.23 and 19.10%. The prevalence of mucoepidermoid carcinoma among British patients with salivary gland tumors has been reported as 2.1%, while the worldwide prevalence ranges from 5 to 15%. 2, 25, 36, 37 The latter range is consistent with our findings (11.49%). Some studies 21, 38 have shown that adenoid cystic carcinoma is more common in the minor salivary glands than in the major glands, while others 4, 39 (including ours) have found the opposite.
Finally, the incidence of secondary malignancies (e.g., metastases) in our study (n = 13; 5.53%) was in general agreement with the findings of others. 3 In conclusion, we believe that our findings contribute significantly to the awareness of the demographic and pathologic features of salivary gland tumors in the Turkish population and that they are similar to what has been reported elsewhere in the world. a whole, with a minimal bias. The mean age at presentation in our study (47 yr) is similar to that reported in previously published series. 6, 21, 24, 25 In addition, the female-to-male ratio in our study was 1.04:1, which is also consistent with other reports that there is a slight female preponderance. 18, [25] [26] [27] The prevalence of salivary gland neoplasms over the 12 years of our study (0.09%) fell within the range of the reported annual prevalence worldwide (0.4 to 13.5 per 100,000 population). 5, 6 Finally, the percentages of benign and malignant tumors in our study (62.13 and 37.87%, respectively) are similar to those of previously reported series (54 to 79% for benign tumors and 21 to 46% for malignancies). 4, 21, 22, 25, 26, 28 Large studies of salivary gland tumors found that between 64 and 80% of all primary epithelial salivary gland tumors occurred in the parotid gland, 7 to 11% in the submandibular gland, fewer than 1% in the sublingual gland, and 9 to 23% in the minor salivary glands. 4, 21, 22, 25, 28 In our series, there were 215 cases of primary tumors; of these 142 (66.05%) occurred in the parotid gland, 31 (14.42%) in the submandibular glands, none in the sublingual gland, and 42 (19.53%) in the minor glands. The lack of sublingual gland involvement in our study confirms previous reports of a low prevalence of tumors at this location. 21, 22 In our study, pleomorphic adenoma was the most common of the 146 benign tumors (67.12%) and, in fact, the most common of all 235 tumors (41.70%). The published prevalence of pleomorphic adenomas among all salivary gland tumors ranges from 40 to 72%. 21, 22, 25, 26, 28 The distribution of the sites of pleomorphic adenoma in our study was similar to that reported by others. 11, 27, 29, 30 Although there are some geographic variations in the prevalence of Warthin tumor worldwide, 2,31,32 the authors of larger series have reported a range of 4 to 13% of all 
